Article
CD40 ligand deficiency: treatment strategies and novel therapeutic perspectives
25 Jan 2019
Abstract excerpt
INTRODUCTION: CD40 ligand (CD40L) deficiency or X-linked Hyper-IgM syndrome is a severe primary immunodeficiency caused by mutations in the CD40L gene. Despite currently available treatments, CD40L-deficient patients remain susceptible to life-threatening infections and have poor long term survival. Areas covered: Here, we discuss clinical and immunological characteristics of CD40L deficiency as well as current...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
